4200 MARATHON BLVD., AUSTIN, TX
Market cap: $16.4M (2/10/2026)
Price: $0.27
Investor Presentation
Announces Pricing of Upsized $15 Million Public Offering
Granted 180-Day Extension to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
Reports Third Quarter Financial Results and Recent Business Highlights
Plus Therapeutics Enters Lease Agreement for New Office Space
Other Events
Files Unaudited Pro Forma Balance Sheet to Show Compliance with Nasdaq Requirement
Reports Second Quarter Financial Results and Recent Business Highlights
Q3
Q2
Q1
Notice of Late Filing for Quarterly Report
Amended Annual Report
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
S-1
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
RW
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
PRER14A
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
S-1MEF
Post-Effective Amendment to Registration Statement